Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients

Pierluigi Navarra, Roberto Cauda, Simona Di Giambenedetto, Massimiliano Fabbiani, Laura Bracciale, Alessandro D'Avino, Angela Marzocchetti, Andrea De Luca, M Doino

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

No abstract available
Original languageEnglish
Pages (from-to)319-321
Number of pages3
JournalJournal of Infection
Volume62
DOIs
Publication statusPublished - 2011

Keywords

  • Adenine
  • Adult
  • Anti-HIV Agents
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • HIV Infections
  • Humans
  • Lamivudine
  • Male
  • Oligopeptides
  • Phosphonic Acids
  • Pyridines
  • Reverse Transcriptase Inhibitors
  • Ritonavir
  • Urolithiasis

Fingerprint

Dive into the research topics of 'Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients'. Together they form a unique fingerprint.

Cite this